Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

COPD

Showing results (541-550 of 1,499) with videos related to

Pageof 150
Sort By:
COPD|July 24, 2013
Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectivesAmir Sharafkhaneh, Ray A Wolf, Sheila Goodnight, et al.
COPD|July 24, 2013
The COPD Pipeline XXIIINicholas Gross
COPD|March 27, 2013
History of the first description of childhood liver disease in AATDHarvey L Sharp
COPD|March 27, 2013
Gene-based therapy for alpha-1 antitrypsin deficiencyChristian Mueller, Terence R Flotte
COPD|March 27, 2013
Alpha-1 antitrypsin deficiency, a corporate perspectiveLawrence D Stern
COPD|March 27, 2013
Alpha-1 antitrypsin augmentation therapyMark D Wewers, Ronald G Crystal
COPD|August 28, 2013
Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizationsVictor Kim, Alice L Sternberg, George Washko, et al.
COPD|September 18, 2013
Biomarkers in COPD: is mortality the Holy Grail?Konstantinos Kostikas, Stelios Loukides, Petros Bakakos
COPD|July 4, 2013
Effects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health StudyEmily Locke, Stephen Thielke, Paula Diehr, et al.
COPD|March 30, 2013
Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patientsLi Zhang, Zhenshun Cheng, Weimin Liu, et al.
Pageof 150

Showing results (541-550 of 1,499) with videos related to

Sort By:
Pageof 150
COPD|July 24, 2013
Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectivesAmir Sharafkhaneh, Ray A Wolf, Sheila Goodnight, et al.
COPD|July 24, 2013
The COPD Pipeline XXIIINicholas Gross
COPD|March 27, 2013
History of the first description of childhood liver disease in AATDHarvey L Sharp
COPD|March 27, 2013
Gene-based therapy for alpha-1 antitrypsin deficiencyChristian Mueller, Terence R Flotte
COPD|March 27, 2013
Alpha-1 antitrypsin deficiency, a corporate perspectiveLawrence D Stern
COPD|March 27, 2013
Alpha-1 antitrypsin augmentation therapyMark D Wewers, Ronald G Crystal
COPD|August 28, 2013
Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizationsVictor Kim, Alice L Sternberg, George Washko, et al.
COPD|September 18, 2013
Biomarkers in COPD: is mortality the Holy Grail?Konstantinos Kostikas, Stelios Loukides, Petros Bakakos
COPD|July 4, 2013
Effects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health StudyEmily Locke, Stephen Thielke, Paula Diehr, et al.
COPD|March 30, 2013
Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patientsLi Zhang, Zhenshun Cheng, Weimin Liu, et al.
Pageof 150